Related Experiment Video
Updated: Feb 22, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types
Christine C Krieger1, Joseph D Perry1, Sarah J Morgan1
1Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Abstract:
We previously showed that thyrotropin (TSH)/insulinlike growth factor (IGF)-1 receptor cross-talk appears to be involved in Graves' orbitopathy (GO) pathogenesis and upregulation of thyroid-specific genes in human thyrocytes. In orbital fibroblasts from GO patients, coadministration of TSH and IGF-1 induces synergistic increases in hyaluronan secretion. In human thyrocytes, TSH plus IGF-1 synergistically increased expression of the sodium-iodide symporter that appeared to involve ERK1/2 activation. However, the details of ERK1/2 activation were not known, nor was whether ERK1/2 was involved in this synergism in other cell types. Using primary cultures of GO fibroblasts (GOFs) and human thyrocytes, as well as human embryonic kidney (HEK) 293 cells overexpressing TSH receptors (HEK-TSHRs), we show that simultaneous activation of TSHRs and IGF-1 receptors (IGF-1Rs) causes rapid, synergistic phosphorylation/activation of ERK1 and ERK2 in all three cell types. This effect is partially inhibited by pertussis toxin, an inhibitor of TSHR coupling to Gi/Go proteins. In support of a role for Gi/Go proteins in ERK1/2 phosphorylation, we found that knockdown of Gi(1-3) and Go in HEK-TSHRs inhibited ERK1/2 phosphorylation stimulated by TSH and TSH plus IGF-1. These data demonstrate that the synergistic effects of TSH plus IGF-1 occur early in the TSHR signaling cascade and further support the idea that TSHR/IGF-1R cross-talk is an important mechanism for regulation of human GOFs and thyrocytes.
Insights
Thyrotropin (TSH) and insulin-like growth factor-1 (IGF-1) receptor cross-talk synergistically activate ERK1/2 signaling in Graves
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- Thyrotropin (TSH)/insulin-like growth factor-1 (IGF-1) receptor cross-talk is implicated in Graves' orbitopathy (GO) pathogenesis.
- TSH and IGF-1 synergistically increase hyaluronan secretion in GO orbital fibroblasts and sodium-iodide symporter expression in thyrocytes.
- The precise mechanism of ERK1/2 activation in this synergism was previously unknown.
Purpose of the Study:
- To investigate the role of ERK1/2 activation in the synergistic effects of TSH and IGF-1.
- To determine if TSHR/IGF-1R cross-talk impacts ERK1/2 activation in GO fibroblasts and thyrocytes.
- To elucidate the early signaling events involved in TSHR/IGF-1R synergism.
Main Methods:
- Primary cultures of Graves' orbitopathy fibroblasts (GOFs) and human thyrocytes.
- Human embryonic kidney (HEK) 293 cells overexpressing TSH receptors (HEK-TSHRs).
- Analysis of ERK1/2 phosphorylation, pertussis toxin inhibition, and Gi/Go protein knockdown.
Main Results:
- Simultaneous TSHR and IGF-1R activation caused rapid, synergistic ERK1/2 phosphorylation in GOFs, thyrocytes, and HEK-TSHRs.
- This synergistic effect was partially inhibited by pertussis toxin, suggesting involvement of Gi/Go proteins.
- Knockdown of Gi(1-3) and Go proteins inhibited TSH-stimulated ERK1/2 phosphorylation.
Conclusions:
- TSHR/IGF-1R cross-talk triggers early synergistic ERK1/2 activation in the TSHR signaling cascade.
- Gi/Go proteins play a role in mediating TSH-induced ERK1/2 phosphorylation.
- This cross-talk mechanism is crucial for regulating GO fibroblasts and thyrocytes.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
Intracellular Signaling Affects Focal Adhesions
Some...

